Detalhe da pesquisa
1.
Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose.
Clin Infect Dis
; 76(3): e234-e239, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35724127
2.
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study.
Infection
; 51(4): 1003-1012, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571672
3.
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
J Antimicrob Chemother
; 76(8): 2172-2181, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993273
4.
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study.
Clin Infect Dis
; 70(11): 2270-2280, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323088
5.
Assessing the impact of a positive Biofire® FilmArray® Meningitis/Encephalitis Panel result on clinical management and outcomes.
Diagn Microbiol Infect Dis
; 104(3): 115769, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964557
6.
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Infect Dis Ther
; 11(4): 1505-1519, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612693
7.
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.
Int J Antimicrob Agents
; 55(2): 105847, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770625